Search Results

Filter
  • 1-10 of  537 results for ""Central Nervous System Neoplasms""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.

  • Authors : Shimada K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan. .; Ohmachi K

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/epidemiology ; Rituximab*/Rituximab*/Rituximab*/therapeutic use CHOP protocol

  • Source: Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2021-2031. Date of Electronic Publication: 2024 Jan 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study.

  • Authors : Hino C; Department of Internal Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA.; Lacy C

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/drug therapy ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/prevention & control

  • Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Oct; Vol. 23 (10), pp. 764-771. Date of Electronic Publication: 2023 Jul 06.Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.

  • Authors : Sakamoto H; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*pathology ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*secondary

  • Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2021 Dec; Vol. 4 (6), pp. e1414. Date of Electronic Publication: 2021 May 07.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost: Prognostic Impact of Human Chorionic Gonadotropin.

  • Authors : Chou YC; Department of Radiation Oncology, Proton and Radiation Therapy Center, Linkou Chang Gung Memorial Hospital.; Wu YY

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*therapy ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*mortality

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Oct 01; Vol. 43 (7), pp. e907-e912.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

  • Authors : Renaud L; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hemato-Oncology, Hôpital Saint-Louis, Paris, France.

Subjects: Adenine/Adenine/Adenine/*analogs & derivatives ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2021 Sep; Vol. 107 (3), pp. 370-373. Date of Electronic Publication: 2021 Jun 01.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

×
Academic Journal

Extramedullary Hematopoiesis in the Dura Mater During Treatment of a CNS Embryonal Tumor.

Subjects: Hematopoiesis, Extramedullary*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*drug therapy

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Nov 01; Vol. 43 (8), pp. e1217-e1219.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.

  • Authors : Fries C; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Rochester, Rochester.; Girvin AR

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*therapy ; Myeloablative Agonists/Myeloablative Agonists/Myeloablative Agonists/*administration & dosage

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Nov 01; Vol. 43 (8), pp. e1223-e1227.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.

  • Authors : Bobillo S; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Subjects: Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/prevention & control ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/secondary; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage

  • Source: Blood cancer journal [Blood Cancer J] 2021 Jun 16; Vol. 11 (6), pp. 113. Date of Electronic Publication: 2021 Jun 16.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).

  • Authors : Liu Y; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China.; Yao Q

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*diagnosis

  • Source: International journal of oncology [Int J Oncol] 2021 Mar; Vol. 58 (3), pp. 371-387. Date of Electronic Publication: 2021 Feb 01.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy

  • Source: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2021 Apr 12; Vol. 73 (4), pp. 231-237. Date of Electronic Publication: 2021 Publisher: Permanyer Country of Publication: Mexico NLM ID: 9421552 Publication Model: Electronic Cited Medium: Internet ISSN: 0034-8376 (Print)

Record details

×
  • 1-10 of  537 results for ""Central Nervous System Neoplasms""